Best Urolithin A Supplement in 2026 — Mitopure vs Generic, Dosing, and What Phase 2 Trials Show

Urolithin A works through mitophagy — a specialized form of autophagy (cellular self-cleaning) that selectively removes damaged mitochondria. **Why mitophagy matters for muscle aging.** Mitochondria are the energy-producing organelles in every cell, but they accumulate damage over time — from reactive oxygen species generated during energy production, from DNA replication errors, and from disruptions to the mitochondrial membrane. In young cells, damaged mitochondria are continuously cleared via mitophagy and replaced with new functional ones. With age, mitophagy efficiency declines. Damaged mitochondria accumulate in muscle cells, producing less energy (ATP), generating more oxidative stress, and triggering inflammatory signaling. This mitochondrial dysfunction is a central mechanism in the age-related muscle decline (sarcopenia) and loss of endurance capacity that most people over 50 begin experiencing. **How Urolithin A activates mitophagy.** When urolithin A enters a cell, it activates the PINK1/Parkin mitophagy pathway: 1. PINK1 (a kinase) accumulates on damaged mitochondria where the membrane potential is reduced 2. PINK1 phosphorylates ubiquitin, which recruits the E3 ligase Parkin 3. Parkin ubiquitinates outer mitochondrial membrane proteins, flagging the damaged mitochondrion for removal 4. The autophagosome (cellular cleanup machine) recognizes these ubiquitin tags and engulfs the damaged mitochondrion 5. The autophagosome fuses with the lysosome, which breaks down the mitochondrial contents for recycling 6. The cell produces new mitochondria to replace the cleared ones — mitochondrial biogenesis The result: the cell has a higher ratio of functional to dysfunctional mitochondria, producing more ATP per mitochondrial mass, generating less oxidative stress, and supporting better muscle contraction and endurance. **Why supplementation is necessary.** Urolithin A is a postbiotic — it is not found in food directly but is produced by gut bacteria (Gordonibacter, Ellagibacter) from ellagitannins in pomegranates, walnuts, raspberries, and strawberries. The problem is microbiome-dependent: approximately 60–70% of adults lack the right gut bacteria to produce meaningful urolithin A levels even from high ellagitannin intake. Among 'non-producers', plasma UA is essentially undetectable regardless of pomegranate consumption. Direct supplementation bypasses this microbiome bottleneck. **Dose-response insight from RCTs.** The Singh et al. 2022 trial established a meaningful dose-response difference: - 500mg/day: improved endurance markers (6-min walk test) and mitochondrial gene expression — mitophagy is activated, but muscle strength outcomes were not statistically significant - 1,000mg/day: added handgrip strength improvement (12%) and walking speed improvements — sufficient mitophagy activation to produce measurable functional muscle improvements This dose-response relationship is important for product selection and dose guidance.

**The central decision: Mitopure vs generic UA.** The compound — Urolithin A — is the same molecule in all products. The difference is clinical evidence. Timeline Mitopure is the only brand whose Phase 2 human RCT has confirmed muscle health effects at specific doses. Generic UA brands have not published Phase 2 RCT data, and whether their manufacturing produces equivalent plasma bioavailability to Mitopure is not publicly confirmed. This creates a genuine trade-off: **If evidence confidence is your priority:** Timeline Mitopure 500–1,000mg/day. The $125–250/month cost is a significant commitment but you are getting a product with validated pharmacokinetics and Phase 2 efficacy data. For maximum muscle strength benefit, target 1,000mg/day (two packs/month). **If cost accessibility is your priority:** Neurogan 1,000mg/day at $1.65/day gets you to the RCT dose with the explicit trade-off that bioavailability equivalence is unconfirmed. This is a reasonable approach for trialing UA before committing to Mitopure pricing. **Trial progression option:** Start with Double Wood (500mg) or Neurogan (1,000mg) for 60 days to establish subjective tolerance and early response. If you perceive benefit and want to invest in the evidence-backed option, transition to Mitopure. **When to expect results:** The Singh et al. 2022 RCT observed significant outcomes at 4 months. Mitophagy induction (mitochondrial quality improvement) takes time to manifest as functional muscle change. Set realistic expectations — 3 months minimum before assessing effect, 4 months to match the trial protocol. **Stacking context.** Urolithin A works on the mitophagy pathway. NMN/NAD+ works on the NAD+ synthesis pathway that supports mitochondrial energy production and DNA repair. These are complementary mechanisms (quality control + fuel supply) and are often combined in longevity protocols. Spermidine also activates autophagy via a separate pathway. These combinations are theoretically additive but have not been tested in human RCTs as combinations.